Magali Haas

2.7k total citations
31 papers, 912 citations indexed

About

Magali Haas is a scholar working on Psychiatry and Mental health, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Magali Haas has authored 31 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 8 papers in Molecular Biology and 8 papers in Cognitive Neuroscience. Recurrent topics in Magali Haas's work include Computational Drug Discovery Methods (5 papers), Traumatic Brain Injury Research (5 papers) and Functional Brain Connectivity Studies (5 papers). Magali Haas is often cited by papers focused on Computational Drug Discovery Methods (5 papers), Traumatic Brain Injury Research (5 papers) and Functional Brain Connectivity Studies (5 papers). Magali Haas collaborates with scholars based in United States, Belgium and Germany. Magali Haas's co-authors include Gahan Pandina, Stuart Kushner, Jorge A. Quiroz, Vivek Kusumakar, Ilse Augustyns, Peter S. Jensen, Jan K. Buitelaar, Carin Binder, Margaret D. Copenhaver and Jorge L. Armenteros and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Biological Psychiatry.

In The Last Decade

Magali Haas

29 papers receiving 873 citations

Peers

Countries citing papers authored by Magali Haas

Since Specialization

Citations

This map shows the geographic impact of Magali Haas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magali Haas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magali Haas more than expected).

Fields of papers citing papers by Magali Haas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magali Haas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magali Haas. The network helps show where Magali Haas may publish in the future.

Co-authorship network of co-authors of Magali Haas

This figure shows the co-authorship network connecting the top 25 collaborators of Magali Haas. A scholar is included among the top collaborators of Magali Haas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magali Haas. Magali Haas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Testing the usefulness of a quality system in preclinical research 2024 ·SHILAP Revista de lepidopterología ·René Bernard, Björn Gerlach, Magali Haas, Malcolm Macleod, Heidrun Potschka, Andrew S.C. Rice, Thomas Steckler, Vootele Võikar, Kimberley E. Wever	1
2	Normative Neuroimaging Library: Designing a Comprehensive and Demographically Diverse Dataset of Healthy Controls to Support Traumatic Brain Injury Diagnostic and Therapeutic Development 2024 ·Journal of Neurotrauma ·Allyson Gage, James R. Stone, Elisabeth A. Wilde, Stephen R. McCauley, Robert C. Welsh, John P. Mugler, Nicholas J. Tustison, Brian Avants, Christopher T. Whitlow, Lee Lancashire, (unknown), Magali Haas	1
3	Predicting mental health treatment outcomes using latent growth mixture models and machine learning in a real-world clinical setting 2024 ·Journal of Psychiatric Research ·Lee Lancashire, Steven L. Lancaster, (unknown), Anthony M. Hassan, Magali Haas, Allyson Gage	1
4	Machine learning within the Parkinson’s progression markers initiative: Review of the current state of affairs 2023 ·Frontiers in Aging Neuroscience ·Raphael T. Gerraty, Allison C. Provost, Lin Li, Erin Wagner, Magali Haas, Lee Lancashire	16
5	Deep Learning for Daily Monitoring of Parkinson’s Disease Outside the Clinic Using Wearable Sensors 2022 ·Sensors ·(unknown), (unknown), Barbara Marebwa, Tanya Simuni, (unknown), Andrew Siderowf, Mark Frasier, Magali Haas, Lee Lancashire	13
6	A Framework to Advance Biomarker Development in the Diagnosis, Outcome Prediction, and Treatment of Traumatic Brain Injury 2022 ·Journal of Neurotrauma ·Elisabeth A. Wilde, (unknown), Kimbra Kenney, Jessica Gill, James R. Stone, Seth G. Disner, Caroline Schnakers, (unknown), Eric M. Prager, Magali Haas, Andreas Jeromin	44
7	Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson’s disease 2020 ·SHILAP Revista de lepidopterología ·Heather C. Lasseter, Allison C. Provost, Lauren Chaby, Nikolaos P. Daskalakis, Magali Haas, Andreas Jeromin	37
8	PTSD Biomarker Database: deep dive metadatabase for PTSD biomarkers, visualizations and analysis tools 2019 ·Database ·Daniel Domingo‐Fernándéz, Allison C. Provost, Alpha Tom Kodamullil, (unknown), Heather C. Lasseter, (unknown), Nikolaos P. Daskalakis, Lee Lancashire, Martin Hofmann‐Apitius, Magali Haas	13
9	Driving Progress in Posttraumatic Stress Disorder Biomarkers 2019 ·Biological Psychiatry ·Andreas Jeromin, Heather C. Lasseter, Allison C. Provost, Nikolaos P. Daskalakis, Amit Etkin, Philip Gehrman, Lee Lancashire, Brian P. Marx, Regina E. McGlinchey, Magali Haas	3
10	The preclinical data forum network: A new ECNP initiative to improve data quality and robustness for (preclinical) neuroscience 2015 ·European Neuropsychopharmacology ·Thomas Steckler, Katja Brose, Magali Haas, Martien J. Kas, Elena Koustova, Anton Bespalov	14
11	Large-scale candidate gene study to identify genetic risk factors predictive of paliperidone treatment response in patients with schizophrenia 2015 ·Pharmacogenetics and Genomics ·Dai Wang, Dong‐Jing Fu, Xiaodong Wu, Alice Shapiro, Reyna Favis, Adam Savitz, (unknown), Larry Alphs, Srihari Gopal, Magali Haas, Nadine Cohen, Qingqin S. Li	13
12	Alzheimer's disease research and development: a call for a new research roadmap 2014 ·Annals of the New York Academy of Sciences ·Howard Feldman, Magali Haas, Sam Gandy, Darryle D. Schoepp, A.J. Cross, Richard Mayeux, Reisa A. Sperling, Howard Fillit, (unknown), Sonya Dougal, Jeffrey S. Nye	30
13	An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia 2012 ·Child and Adolescent Psychiatry and Mental Health ·Gahan Pandina, Stuart Kushner, Keith Karcher, Magali Haas	17
14	A 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Risperidone in Adolescents with Schizophrenia 2009 ·Journal of Child and Adolescent Psychopharmacology ·Magali Haas, Alan S. Unis, Jorge L. Armenteros, Margaret D. Copenhaver, Jorge A. Quiroz, Stuart Kushner	100
15	Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double‐blind, placebo‐controlled study 2009 ·Bipolar Disorders ·Magali Haas, Melissa P. DelBello, Gahan Pandina, Stuart Kushner, Ilse Van Hove, Ilse Augustyns, Jorge A. Quiroz, Vivek Kusumakar	120
16	Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo‐controlled trials 2009 ·Epilepsia ·Michael R. Sperling, Andrew Greenspan, Joyce A. Cramer, Patrick Kwan, Reetta Kälviäinen, Jonathan J. Halford, (unknown), Eric Yuen, Thomas D. Cook, Magali Haas, Gerald Novak	39
17	Evaluation of Carisbamate for the Treatment of Migraine in a Randomized, Double‐Blind Trial 2009 ·Headache The Journal of Head and Face Pain ·Roger Cady, Ninan T. Mathew, Hans‐Christoph Diener, Peter Hu, Magali Haas, Gerald Novak	25
18	Treating Disruptive Behavior Disorders with Risperidone: A 1-Year, Open-Label Safety Study in Children and Adolescents 2008 ·Journal of Child and Adolescent Psychopharmacology ·Magali Haas, Keith Karcher, Gahan Pandina	22
19	Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures 2008 ·Neurology ·Edward Faught, Gregory L. Holmes, William E. Rosenfeld, Gerald Novak, Walter Krause Neto, Andrew Greenspan, Jeffrey D. Schmitt, Eunice Yuen, S. Reines, Magali Haas	39
20	Management of psychiatric disorders in children and adolescents with atypical antipsychotics 2006 ·European Child & Adolescent Psychiatry ·Peter S. Jensen, Jan K. Buitelaar, Gahan Pandina, Carin Binder, Magali Haas	85

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact